Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted
20 Dicembre 2023 - 3:02PM
Update on the merger approval process for the combination of
Novozymes and Chr. Hansen: South Korean merger approval granted
December 20, 2023
Please see attachment.
Contact information
Investor RelationsDisa Tuominen+45 6038
5826dkditu@chr-hansen.com
Press RelationsSanne Seyer-Hansen+45 6038
6207dksash@chr-hansen.com
- 2023_South Korean merger approval granted
Grafico Azioni Chr Hansen (TG:51C)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Chr Hansen (TG:51C)
Storico
Da Set 2023 a Set 2024